InsidersTradesSigma
申报总数
公司
▲ 买入（18 笔）
▼ 卖出（9 笔）
内部人交易记录
其他已披露买入
18
已披露卖出
9
T+90 胜率
0%
T+90 平均收益
-31.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Redmile Group, LLC. Director active across 17 companies, notably Fate Therapeutics INC. Cumulatively, 81 filings have been recorded. Split: 18 buys · 9 sells. Total volume traded: €43m. Activity tracked since 2 June 2021. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Redmile Group, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报81 总计
782,854 股Common StockSEC:0001104659-26-092867:0
200,000 股@ US$17.000.15% mcap33.3% 占其流量Common StockSEC:0001104659-26-092867:1
标准退出：2026年11月4日 (T+90)
400,000 股@ US$17.000.30% mcap66.7% 占其流量Common StockSEC:0001104659-26-092867:2
标准退出：2026年11月4日 (T+90)
60 股Common StockSEC:0001104659-26-086733:1
195,211 股Common StockSEC:0001104659-26-086733:0
8,977,624 股0Common StockSEC:0001104659-26-047072:0
8,977,624 股0Common StockSEC:0001104659-26-047072:1
196,229 股@ US$3.7523.5% 占其流量Common StockSEC:0001104659-26-039359:0
188,407 股@ US$3.7523.4% 占其流量Common StockSEC:0001104659-26-039359:1
169,265 股@ US$3.7993.0% 占其流量Common StockSEC:0001104659-26-039359:2
162,517 股@ US$3.7992.9% 占其流量Common StockSEC:0001104659-26-039359:3
2,634,506 股@ US$3.27941.1% 占其流量Common StockSEC:0001104659-26-039359:4
2,529,491 股@ US$3.27939.5% 占其流量Common StockSEC:0001104659-26-039359:5
2,964,843 股Common StockSEC:0001104659-25-079307:0
828 股0Common StockSEC:0001104659-25-065256:0
828 股0Common StockSEC:0001104659-25-031353:0
1,734 股0Common StockSEC:0001104659-25-000432:0
1,084,936 股@ US$1.6823.6% 占其流量Common StockSEC:0001104659-24-131794:0
30,110 股Common StockSEC:0001104659-24-129070:0
50,000 股@ US$2.289.0% 占其流量Common Shares, par value CHF 0.08 per shareSEC:0001104659-24-128575:0
标准退出：2025年3月11日 (T+90)
133,371 股@ US$1.25100.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001104659-24-126421:0
25,352 股@ US$2.074.1% 占其流量Common Shares, par value CHF 0.08 per shareSEC:0001104659-24-126422:0
16,421,788 股@ US$2.3559.5% 占其流量Common StockSEC:0001104659-24-106315:0
1,734 股0Common StockSEC:0001104659-24-105559:0
400,000 股@ US$2.8186.9% 占其流量Common Shares, par value CHF 0.08 per shareSEC:0001104659-24-077865:0
标准退出：2024年9月29日 (T+90)
81 条申报中的 25 条
About Redmile Group, LLC
Redmile Group, LLC has 76 filings in total. In the sampled recent filings we hold, from 2016-01-11 to 2026-04-22, the reported buy amount is EUR 16224333 and the reported sell amount is EUR 52839723. The modal transaction nature is Attribution; the listed companies include IGM Biosciences, Inc., Augmedix, Inc., Fate Therapeutics INC, ADC Therapeutics SA, ARRAY BIOPHARMA INC, and Science 37 Holdings, Inc.
